These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17966685)

  • 1. Drug-induced long QT syndrome.
    Letsas KP; Efremidis M; Filippatos GS; Sideris AM
    Hellenic J Cardiol; 2007; 48(5):296-9. PubMed ID: 17966685
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired long QT syndrome and phosphoinositide 3-kinase.
    Cohen IS; Lin RZ; Ballou LM
    Trends Cardiovasc Med; 2017 Oct; 27(7):451-459. PubMed ID: 28687226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiologist's point of view: Novel ECG biomarkers and in silico models for proarrhythmic risk prediction: Are we ready?
    Mason JW
    J Electrocardiol; 2017; 50(6):825-827. PubMed ID: 28919218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine.
    Stas P; Faes D; Noyens P
    Int J Cardiol; 2008 Jul; 127(2):e80-2. PubMed ID: 17590456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine and acquired long QT syndrome.
    Endo T; Katoh T; Kiuchi K; Katsuta Y; Shimizu S; Takano T
    Am J Med; 2000 Apr; 108(5):438-9. PubMed ID: 10759110
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac conduction and antipsychotic medication: a primer on electrocardiograms.
    Carroll DH; Shyam R; Scahill L
    J Child Adolesc Psychiatr Nurs; 2002; 15(4):170-7. PubMed ID: 12562135
    [No Abstract]   [Full Text] [Related]  

  • 7. Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
    Said TH; Wilson LD; Jeyaraj D; Fossa AA; Rosenbaum DS
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):165-71. PubMed ID: 22561361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
    Takahara A; Sugiyama A; Hashimoto K
    Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enlargement of QT-interval in a patient with coronary disease treated with mianserin].
    Hidalgo Urbano RJ; Díaz Infante E; Recio Mayoral A; López Rincón F; Gutiérrez de la Peña J; Cruz Fernández JM
    An Med Interna; 2003 Dec; 20(12):656-8. PubMed ID: 14697094
    [No Abstract]   [Full Text] [Related]  

  • 11. Antipsychotic medications and cardiac conduction risks.
    Roman M; Farmer SY
    Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166
    [No Abstract]   [Full Text] [Related]  

  • 12. Ranolazine-induced Repolarization Changes: A Case Report.
    Kumthekar A; Cossarini F; Shih JC; Taub CC; Massera D
    Am J Med; 2015 Jul; 128(7):e3-5. PubMed ID: 25660248
    [No Abstract]   [Full Text] [Related]  

  • 13. KCNE1 G38S polymorphism is not the cause of long QT syndrome.
    Kanters JK; Olesen MS; Christiansen M
    J Electrocardiol; 2016; 49(2):249-50. PubMed ID: 26781364
    [No Abstract]   [Full Text] [Related]  

  • 14. Two types of T wave alternans in long-QT syndrome.
    Shu J; Li Y; Ju R; Yan GX
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):910-912. PubMed ID: 24724570
    [No Abstract]   [Full Text] [Related]  

  • 15. Quetiapine and the need for a thorough QT/QTc study.
    Hasnain M; Vieweg WV; Howland RH; Kogut C; Breden Crouse EL; Koneru JN; Hancox JC; Digby GC; Baranchuk A; Deshmukh A; Pandurangi AK
    J Clin Psychopharmacol; 2014 Feb; 34(1):3-6. PubMed ID: 24346758
    [No Abstract]   [Full Text] [Related]  

  • 16. Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.
    Schutte D; Obel W
    Cardiovasc J S Afr; 2002; 13(2):54-61. PubMed ID: 11981581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids-Induced Long QT Syndrome: A Challenge to Cardiac Health.
    Hu J; Song Y; Huang X; Li C; Jin X; Cen L; Zhang C; Ding B; Lian J
    Cardiovasc Toxicol; 2024 May; 24(5):472-480. PubMed ID: 38630336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.
    Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long QT syndrome. Why does sex matter?
    Kääb S; Pfeufer A; Hinterseer M; Näbauer M; Schulze-Bahr E
    Z Kardiol; 2004 Sep; 93(9):641-5. PubMed ID: 15365730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Mar; 146(10):451-60. PubMed ID: 15835343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.